---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-007788"
form_type: "8-K"
ticker: "CMPS"
cik: "0001816590"
company_name: "COMPASS Pathways plc"
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:13:56.765441+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Compass Pathways Q4 2023 net loss $32.5M; COMP005 data delayed to Q4 2024

## Summary
- Net loss for FY2023 $118.5M ($2.32/sh) vs $91.5M ($2.16/sh) in 2022.
- Cash $220.2M at Dec 31, 2023; raised additional $31.4M net in Q1 2024.
- COMP005 phase 3 top-line data delayed to Q4 2024; COMP006 still on track for mid-2025.
- Teri Loxam appointed CFO effective March 1, 2024.
- FY2024 net cash used in operations expected $110-130M; runway into late 2025.

## SEC filing metadata
- accession: 0001628280-24-007788
- form_type: 8-K
- ticker: CMPS
- cik: 0001816590
- company_name: COMPASS Pathways plc
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816590/000162828024007788/0001628280-24-007788-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816590/000162828024007788/cmps-20240229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-007788
- JSON: https://secwatch.observer/filing/0001628280-24-007788.json
- Plain text: https://secwatch.observer/filing/0001628280-24-007788.txt

## Key facts
- Earnings Releases
  COMPASS Pathways plc reported fourth quarter and year ended December 31, 2023 results: net income Net loss for the year ended December 31, 2023, was $118.5 million, or $2.32 loss per share, EPS $2.32 loss per share.
  - Period: fourth quarter and year ended December 31, 2023
  - Net income: Net loss for the year ended December 31, 2023, was $118.5 million, or $2.32 loss per share
  - EPS: $2.32 loss per share
  - Result: reported results
  source text: Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter 2023 and provided an update on recent progress across its business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816590/000162828024007788/0001628280-24-007788-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.